Panavance Therapeutics
  • Our Science
    • Pipeline
    • About Misetionamide
    • Mechanism of Action
  • About
    • About Persevere
    • Leadership
    • Advisors
    • Contact Persevere
  • Resources
    • Publications
    • Press Releases

Let’s engage.

Mechanisms and rational combinations with GP-2250, a novel oxathiazine derivative, in ovarian cancer

November 9, 2023 / 0 Minute Read

persevere therapeutics

  • Our Science
  • About
  • Resources
  • LinkedIn

+1.610.922.1910

Copyright © 2026 Persevere Therapeutics Inc.